Edetate Calcium Disodium and Succimer in Treating Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Conditions: Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome; Myelodysplastic/Myeloproliferative Neoplasm; Secondary Acute My eloid Leukemia Interventions: Drug: Edetate Calcium Disodium; Dietary Supplement: Multivitamin; Drug: Succimer Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Myeloid Leukemia | Calcium | Cancer & Oncology | Chemotherapy | Leukemia | Myelodysplastic Syndrome | Nutrition